Anti-Cancer Agents in Medicinal Chemistry, Volume 13 - Number 3

Editorial (Hot Topic: Recent Development of Molecular Targeted Anti-Cancer Agents)

, 13(3): 381

Feng Liang and Yong Zeng

DOI: 10.2174/187152013804910406

Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy

, 13(3): 382 - 388

Roland Leung, Brian Lang, Hilda Wong, Joanne Chiu, Wan K. Yat, Tony Shek, Woo Y. Cho, Lo C. Yau and Thomas Yau

DOI: 10.2174/1871520611313030002

Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives

, 13(3): 389 - 402

Alexandre Bozec, Frederic Peyrade and Gerard Milano

DOI: 10.2174/187152013804910370

Multifunctionalized Microbubbles for Cancer Diagnosis and Therapy

, 13(3): 403 - 413

Hao Li, Jianhao Wang, Gang Huang, Ping Wang, Rongqin Zheng, Chao Zhang and Qing Jiang

DOI: 10.2174/1871520611313030004

Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line

, 13(3): 414 - 421

Raquel T. Lima, Gemma A. Barron, Joanna A. Grabowska, Giovanna Bermano, Simranjeet Kaur, Nilanjan Roy, M. Helena Vasconcelos and Paul K.T. Lin

DOI: 10.2174/1871520611313030005

Heterocyclic Chalcone Analogues as Potential Anticancer Agents

, 13(3): 422 - 432

Vikas Sharma, Vipin Kumar and Pradeep Kumar

DOI: 10.2174/1871520611313030006

Biology and Medicinal Chemistry Approaches Towards Various Apoptosis Inducers

, 13(3): 433 - 455

Vivek K. Vyas, Chetan Chintha and Mitul R. Pandya

DOI: 10.2174/1871520611313030007

Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents

, 13(3): 456 - 463

Jin-Jian Lu, Jiao-Lin Bao, Guo-Sheng Wu, Wen-Shan Xu, Ming-Qing Huang, Xiu-Ping Chen and Yi-Tao Wang

DOI: 10.2174/1871520611313030008

Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies

, 13(3): 464 - 475

Jinjia Chang and Weimin Fan

DOI: 10.2174/1871520611313030009

Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma

, 13(3): 476 - 482

Patroklos Katafygiotis, Constantinos Giaginis, Efstratios Patsouris and Stamatios Theocharis

DOI: 10.2174/1871520611313030010

Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer

, 13(3): 483 - 495

Jose M.G. Saez

DOI: 10.2174/1871520611313030011

Redox-inactive Analogue of Tocotrienol as a Potential Anti-cancer Agent

, 13(3): 496 - 501

Tomohiro Yano, Ayami Sato, Miki Sekine, Nantiga Virgona and Masako Ota

DOI: 10.2174/1871520611313030012

NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy

, 13(3): 502 - 514

Urbain Weyemi, Christophe E. Redon, Palak R. Parekh, Corinne Dupuy and William M. Bonner

DOI: 10.2174/1871520611313030013

Targeting Heme for the Identification of Cytotoxic Agents

, 13(3): 515 - 522

Shiming Zhang, Hui Chen, Jessica Webster and Glenn S. Gerhard

DOI: 10.2174/1871520611313030014

Human Skin-Derived Fibroblasts Acquire In Vitro Anti-Tumor Potential after Priming with Paclitaxel

, 13(3): 523 - 530

Augusto Pessina, Valentina Cocce, Arianna Bonomi, Loredana Cavicchini, Francesca Sisto, Maura Ferrari, Emilio Ciusani, Stefania Navone, Giovanni Marfia, Eugenio Parati and Giulio Alessandri

DOI: 10.2174/1871520611313030015

Webmaster Contact:
Copyright © 2018 Bentham Science